Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 3;10(1):234–244. doi: 10.1002/ehf2.14173

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Comparison of notable red flags in the study population and the matched ATTRwt controls. (A) IVS, (B) GLS, (C) RASr, and (D) NT‐proBNP. ATTRwt, wild‐type transthyretin cardiac amyloidosis; DPD, technetium‐99m 3,3‐diphosphono‐1,2‐propanodicarboxylic acid scintigraphy; GLS, global longitudinal strain; IVS, interventricular septum; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; RASr, relative apical sparring ratio. *Significant difference between ‘suspicion, confirmed ATTRwt’, ‘no suspicion’, and ‘suspicion, not confirmed’. **Significant difference between ‘matched clinical ATTRwt’ and ‘suspicion, confirmed ATTRwt’.